TranslatePriority 20 from the Hyperemesis Gravidarum PSP
| UNCERTAINTY: What are the barriers to taking/prescribing medication for hyperemesis gravidarum? How can the risk and benefits of hyperemesis gravidarum and it's treatments be better communicated to support informed decision making and consent to treatment? (JLA PSP Priority 20) | |
|---|---|
| Overall ranking | 20 |
| JLA question ID | 0090/20 |
| Explanatory note | Not available for this PSP |
| Evidence |
Some barriers identified but no conclusive studies within HG literature. A wider search regarding medication use in pregnancy may yeild more insight which is applicable to HG? |
| Health Research Classification System category | Reproductive health and childbirth |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | The biggest worry is taking medication and any impact that may have on your baby, clear advice and information needs to be provided prior to taking any medication. I was only offered stemitil which didn't help and only learned afterwards other medication was available. |
| Submitted by | Patients x 11 ~ Healthcare professionals x 2 ~ Offspring x 2 ~ Unknown x 1 |
| PSP information | |
|---|---|
| PSP unique ID | 0090 |
| PSP name | Hyperemesis Gravidarum |
| Total number of uncertainties identified by this PSP. | 65 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 9 October 2019 |
